Quantifying the Respiratory Burden: Evaluating the Global Bronchitis Treatment Market Size in 2026
The economic impact of respiratory diseases is a central concern for healthcare policymakers worldwide. Bronchitis, both in its acute viral form and its chronic COPD-related form, accounts for billions of dollars in annual healthcare spending. This includes direct costs such as hospital admissions, diagnostic testing, and medication, as well as indirect costs like lost productivity and...
0 Comments 0 Shares 989 Views 0 Reviews